SOCIETY FOR BRAIN MAPPING AND THERAPEUTICS

SOCIETY FOR BRAIN MAPPING AND THERAPEUTICS

BREAKING BOUNDARIES OF SCIENCE, TECHNOLOGY, MEDICINE, ART & HEALTHCARE POLICY

Session Chair: Christopher J. Wheeler, Ph.D.

8:00 – 8:15 AM
Age-related CD8 T Cells as Initators, Biomarkers, and Potential Therapeutic Targets in Sporadic Alzheimer’s

Christopher J. Wheeler, Ph.D.

Senior Research Scientist SBMT; Chief Science Officer, T-Neuro Pharma; President, StemVax Therapeutics

8:15 – 8:30 AM
The Impact of Methionine Oxidation on Amyloid Beta 1-42 Aggregation

Ka Chan

Grad. Student UC Santa Cruz

8:30 – 8:45 AM
Testing the CAMPS Hypothesis: Improved Treatment for Neurodegenerative Diseases [CAMPS: Cytotoxic Aggregated Misfolded Polymorphic Structures]

William Rodman Shankle, MD

Director, Shankle Clinic for Memory and Cognition Research Fellow, UC Irvine Cognitive Science Dept. Voltmer Chair, Memory and Cognitive Disorders, Pickup Family Neurosciences Institute Chief Medical Officer, EMBIC Corp., USA

8:45 – 9:00 AM
A Step Closer to Early Alzheimer’s Diagnosis: The Power of an Ultrasensitive Blood Test

Ali Yanik, PhD

Associate Professor in Baskin School of Engineering, University of California, Santa Cruz, USA

9:00 – 9:15 AM
CAA and ARIA in the Era of Anti-Amyloid Therapy

Edward Zamrini, MD
Director of Neurology, Irvine Clinical Research, CA, USA

9:15 – 9:30 AM
Q & A

Session Chairs

March 16 @ 08:00
08:00 — 09:30 (1h 30′)

Room 409 B

Alzheimer’s Disease and Dementia

Add